Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Marketing Plan Article
This is a selection made from among articles on Drug Treatment Marketing Plan. For a permanent link to this article, or to bookmark it for future reading, click here.
Signs of Drug Addiction
from:Drug addiction is an insidious disease that takes over a persons life and clouds their world in a fog of problems and struggles. The signs of drug addiction are many and varied depending on what type of drug is being abused.
Different drugs affect people in different ways. For example, marijuana may make a person appear spaced out and distant while amphetamines will appear hyper and upbeat. Some people are more prone to addiction as some drugs are more likely to bring about an addiction than others.
If you have been using drugs and are concerned that you may have an addiction, look for the following signs:
* An increase or decrease in appetite, changes in eating habits, or a sudden weight loss
* Changes in personality with no other identifiable cause
* Loss of interest in activities you used to find enjoyable
* Difficult in paying attention or forgetfulness
* Lack of motivation and energy
* Fitful sleep
* Paranoia
* Trouble with managing money
* Inability to stop using your drug of choice
* Excessive pre-occupation with your drug supply
* Doing things you normally wouldnt do if not on the drug
* Use of drugs despite health problems or warnings
* Change in personal grooming habits like showering and changing clothes
The signs of drug addiction in others are similar to those listed above. You can also look for the following indicators as well:
* Smell of substance on clothes (e.g. marijuana, chemicals)
* Sudden need for privacy
* Violent temper or bizarre behavior
* Secretive or suspicious behavior
* Defensiveness or excessive laziness
* Unusual effort to cover up legs and arms
* Unexplained silliness or giddiness
* Drop in school or work performance
* Changes in friends
* Extreme hyperactivity or excessive talktativeness
If you notice any of these signs, a drug addiction could very well be present. Its important that these signs are not ignored and that help is sought for either you or a loved one. The longer a drug addiction lasts, the more damage it can do to the mind and body, so getting help for the addiction is the best course of action.
Its certainly easier to simply ignore any possibility that a drug addiction exists, but when you see the signs, it should become clear that there is a problem. Once the problem is identified, it can effectively be tackled and overcome with the right treatment. Looks for the signs of drug addiction and then face the problem. Its the only way you can win the fight!
Drug Treatment Marketing Plan Specific links
Drug Treatment Marketing Plan News
World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance ... - MarketWatch (press release)
 Proactive Investors UK | World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance ... MarketWatch (press release) COLUMBIA, Md., May 17, 2012 (BUSINESS WIRE) -- Osiris Therapeutics Inc. (NASDAQ:OSIR) announced today it has received market authorization from Health Canada to market its stem cell therapy Prochymal(R) (remestemcel-L), for the treatment of acute ... First stem cell drug approved for systemic disease treatment |
Gaithersburg drug-maker signs deal for European market - Gazette.Net: Maryland Community News Online
Gaithersburg drug-maker signs deal for European market Gazette.Net: Maryland Community News Online Uridine triacetate has not received marketing approval, but is available to US patients under emergency use and other protocols. BTG plans to make it available in the European Union to certain patients under its “named patient” program. |
Drugmakers vulnerable if US health law revoked - CANOE
Drugmakers vulnerable if US health law revoked CANOE Economic concerns could revive ambitious proposals to cut medical costs by reimporting cheaper drugs from other countries, cutting pharmaceutical prices for the government-run Medicare and Medicaid health plans, and even replacing private insurance ... |
Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for ... - MarketWatch (press release)
Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for ... MarketWatch (press release) [3] The trial randomized 77 patients with heFH whose LDL-cholesterol (LDL-C) levels remained uncontrolled on statin therapy with or without ezetimibe. Across the four different dosing regimens tested, patients receiving SAR236553/REGN727 for 12 weeks ... |
Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for ... - MarketWatch (press release)
Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for ... MarketWatch (press release) Expecting to obtain approval for production in the next three months, the Company plans to launch the drug to the market in the second half of the year, with hospitals as its major target market. It will be manufactured by Beijing Sihuan Pharmaceutical ... |
Merck and Mylan Look to Benefit From Plan to Speed up FDA Reviews - MarketWatch (press release)
Merck and Mylan Look to Benefit From Plan to Speed up FDA Reviews MarketWatch (press release) New products that are being introduced into the market place are not expected to generate the same levels of revenues of top selling drugs that have lost patent protection, but a plan to speed up reviews of new drugs and medical devices will look to ... |
Tranzyme Pharma and Norgine Announce Top-Line Data From ULISES 008, the Second ... - MarketWatch (press release)
Tranzyme Pharma and Norgine Announce Top-Line Data From ULISES 008, the Second ... MarketWatch (press release) The study was designed to randomize approximately 330 patients to once-daily IV administration of either 160 or 480 micrograms/kg of study drug, or placebo. The primary endpoint was the time to recovery of GI function as defined by the time from the ... |
Ed Nemeth - Lodi News-Sentinel
Ed Nemeth Lodi News-Sentinel Having owned a series of small start-up companies, Elk Grove resident Ed Nemeth plans to focus on finding ways to create jobs. After graduating with a degree in marketing and finance from Northwestern University's School of Management, Nemeth said he ... |
Apricus Biosciences Granted Regulatory Guidance With FDA for MycoVa(TM) for ... - MarketWatch (press release)
Apricus Biosciences Granted Regulatory Guidance With FDA for MycoVa(TM) for ... MarketWatch (press release) Apricus Bio currently markets Totect(R) (dexrazoxane HCl), the only drug approved in the US for the treatment of anthracycline extravasation. The Company also plans to market in the US or certain other countries the following products: (a) Granisol(R) ... FDA grants regulatory guidance for nail fungus treatment |
Auxilium Pharmaceuticals, Inc. and FCB I LLC File Lawsuit Against Watson for ... - MarketWatch (press release)
Auxilium Pharmaceuticals, Inc. and FCB I LLC File Lawsuit Against Watson for ... MarketWatch (press release) Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences. Auxilium markets Testim® 1% (testosterone gel) for the topical treatment of hypogonadism in ... |